3Zambon M, Hays J, Webster A, et al. Diagnosis of influenza in the community:relationship of clinical diagnosis to confirmed virological,serologic, or molecular detection of influenza. Arch Intern Med,2001,161:2116-2122.
4de Jong JC, Beyer WE, Palache AM, et al. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A (H3N2 ) virus strain as the cause of an inadeqfiate vaccine-induced antibody response to this strain in the elderly. J Med Virol,2000,61:94-99.
二级参考文献10
1Hayden FG,Hay AJ. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Curr Top Microbiol Immunol,1992,176:119-130.
2Whitley RJ,Hayden FG,Reisinger KS,et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J,2001,20:127-133.
3Upshur RE,Knight K,Goel V. Time-series analysis of the relation between influenza virus and hospital admissions of the elderly in Ontario,Canada,for pneumonia,chronic lung disease,and congestive heart failure. Am J Epidemiol,1999,149:85-92.
4Narukawa M,K Minezaki K,Okubo M,et al. Impact of an influenza pandemic on the mortality of congestive heart failure in older Japanese:the 1998 Japanese influenza pandemic. J Am Geriatr Soc,2001,49:689-690.
5Martin C,Mahoney P,Ward P,et al. Oral oseltamivir reduces febrile illness and is safe in patients with chronic cardiac and/or respiratory disease. World Congress on Lung Health,Florence,2000.
6Kaiser L,Wat C,Mills T,et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med,2003,163:1667-1672.
7Treanor JJ,Hayden FG,Vrooman PS,et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza:a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA,2000,283:1016-1024.
